30
Jan
Montpellier, January 30, 2025 – Cilcare, a biotechnology company specializing in auditory sciences, is pleased to announce the appointment of Dr. Preethi Sundaram to its Board of Directors. With 25 years of experience in the pharmaceutical industry, Dr. Sundaram brings exceptional expertise in drug development, commercialization, and business development strategies, including mergers and acquisitions. She joins Cilcare at a strategic juncture to contribute to the company’s mission of leveraging precision auditory sciences to redefine and reimagine the future of care...